IMNM
Immunome
$22.58
+$0.37 (+1.67%)Jul 27, 2026
Key metrics
The numbers that frame IMNM today
- Market cap
- $2.56B
- P/E (TTM)
- -11.4
- EV / FCF
- -9.6
- Gross margin
- 100%
- EV / Sales
- 492.6
- ROIC
- -669.9%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $8.67
- 52wk High
- $27.65
Growth
Revenue and earnings trend for IMNM
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about IMNM
Is Immunome a good buy?
No. Immunome has strong momentum, but poor quality undercuts the setup. Growth looks poor. That could put pressure on the long-term business case. We think Immunome is selling at a very high price.
What is the market capitalization of IMNM?
Immunome's market capitalization is $2.56B.
What is the P/E ratio for IMNM stock?
Immunome's current P/E ratio is -11.4.
What is the 52-week high for IMNM stock?
The 52-week high for Immunome is $27.65. The current close of $22.58 is 18.3% below that high.
What is the 52-week low for IMNM stock?
The 52-week low for Immunome is $8.67. The current close of $22.58 is 160.6% above that low.
Does IMNM stock pay dividends?
Immunome does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for IMNM?
Immunome's Debt / Equity ratio is 0.01.